108 related articles for article (PubMed ID: 29870815)
1. Targeting α1 inserted domain (I) of α1β1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis.
Morjen M; Othman H; Abdelkafi-Koubaa Z; Messadi E; Jebali J; El Ayeb M; Abid NS; Luis J; Marrakchi N
Int J Biol Macromol; 2018 Oct; 117():790-799. PubMed ID: 29870815
[TBL] [Abstract][Full Text] [Related]
2. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
[TBL] [Abstract][Full Text] [Related]
4. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
5. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
[TBL] [Abstract][Full Text] [Related]
6. The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.
Ghazaryan N; Movsisyan N; Macedo JC; Vaz S; Ayvazyan N; Pardo L; Logarinho E
Invest New Drugs; 2019 Oct; 37(5):1044-1051. PubMed ID: 30680583
[TBL] [Abstract][Full Text] [Related]
7. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
[TBL] [Abstract][Full Text] [Related]
8. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
[TBL] [Abstract][Full Text] [Related]
9. PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells.
Morjen M; Kallech-Ziri O; Bazaa A; Othman H; Mabrouk K; Zouari-Kessentini R; Sanz L; Calvete JJ; Srairi-Abid N; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2013 Jan; 32(1):52-62. PubMed ID: 23262217
[TBL] [Abstract][Full Text] [Related]
10. Mapping of potent and specific binding motifs, GLOGEN and GVOGEA, for integrin α1β1 using collagen toolkits II and III.
Hamaia SW; Pugh N; Raynal N; Némoz B; Stone R; Gullberg D; Bihan D; Farndale RW
J Biol Chem; 2012 Jul; 287(31):26019-28. PubMed ID: 22654115
[TBL] [Abstract][Full Text] [Related]
11. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
[TBL] [Abstract][Full Text] [Related]
12. Leberagin-C, A disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion.
Limam I; Bazaa A; Srairi-Abid N; Taboubi S; Jebali J; Zouari-Kessentini R; Kallech-Ziri O; Mejdoub H; Hammami A; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2010 Mar; 29(2):117-26. PubMed ID: 19808093
[TBL] [Abstract][Full Text] [Related]
13. Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.
Momic T; Cohen G; Reich R; Arlinghaus FT; Eble JA; Marcinkiewicz C; Lazarovici P
Toxins (Basel); 2012 Oct; 4(10):862-77. PubMed ID: 23162702
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki.
Lecht S; Chiaverelli RA; Gerstenhaber J; Calvete JJ; Lazarovici P; Casewell NR; Harrison R; Lelkes PI; Marcinkiewicz C
Biochim Biophys Acta; 2015 Jun; 1850(6):1169-79. PubMed ID: 25665484
[TBL] [Abstract][Full Text] [Related]
15. MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration.
Bazaa A; Luis J; Srairi-Abid N; Kallech-Ziri O; Kessentini-Zouari R; Defilles C; Lissitzky JC; El Ayeb M; Marrakchi N
Matrix Biol; 2009 May; 28(4):188-93. PubMed ID: 19351557
[TBL] [Abstract][Full Text] [Related]
16. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
[TBL] [Abstract][Full Text] [Related]
17. Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.
Hammouda MB; Riahi-Chebbi I; Souid S; Othman H; Aloui Z; Srairi-Abid N; Karoui H; Gasmi A; Magnenat EM; Wells TNC; Clemetson KJ; Rodríguez-López JN; Essafi-Benkhadir K
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):600-614. PubMed ID: 29196192
[TBL] [Abstract][Full Text] [Related]
18. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.
Moraes JA; Frony AC; Dias AM; Renovato-Martins M; Rodrigues G; Marcinkiewicz C; Assreuy J; Barja-Fidalgo C
Atherosclerosis; 2015 Dec; 243(2):477-85. PubMed ID: 26520903
[TBL] [Abstract][Full Text] [Related]
19. Vimocin and vidapin, cyclic KTS peptides, are dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity.
Momic T; Katzehendler J; Benny O; Lahiani A; Cohen G; Noy E; Senderowitz H; Eble JA; Marcinkiewicz C; Lazarovici P
J Pharmacol Exp Ther; 2014 Sep; 350(3):506-19. PubMed ID: 24939421
[TBL] [Abstract][Full Text] [Related]
20. Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth.
Brown MC; Staniszewska I; Del Valle L; Tuszynski GP; Marcinkiewicz C
Int J Cancer; 2008 Nov; 123(9):2195-203. PubMed ID: 18712720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
